BridgeBio Pharma, Inc. ( BBIO ) is currently at $39.90, up $0.88 or 2.24%
--Would be highest close since Jan. 10, 2024, when it closed at $39.90
--Currently up nine consecutive days; up 23.7% over this period
--Longest winning streak on record (Based on available data back to June 27, 2019)
--Best nine day stretch since the nine days ending Jan. 24, 2025, when it rose 29.26%
--Up 16.51% month-to-date
--Up 45.43% year-to-date
--Down 44.84% from its all-time closing high of $72.35 on Feb. 8, 2021
--Up 45.21% from 52 weeks ago (June 11, 2024), when it closed at $27.48
--Would be a new 52-week closing high
--Up 78.55% from its 52-week closing low of $22.35 on Nov. 18, 2024
--Traded as high as $40.40; highest intraday level since Feb. 15, 2024, when it hit $41.04
--Up 3.51% at today's intraday high
All data as of 11:23:07 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 10, 2025 11:26 ET (15:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。